Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Active not recruiting 1

Sponsor Class

NIH 1INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 3Genitourinary 3Thoracic 1Other hematologic neoplasm 1Head & Neck 1Gynecologic 1Gastrointestinal 1Dermatologic 1Classical hematology 1Breast 1

Conditions

Melanoma 284Lymphoma, T-Cell, Cutaneous 108Mycosis Fungoides 83Sezary Syndrome 80Lymphoma, Non-Hodgkin 74Leukemia, Lymphocytic, Chronic, B-Cell 74Lymphoma, Large B-Cell, Diffuse 72Lymphoma, Follicular 71Precursor Cell Lymphoblastic Leukemia-Lymphoma 70Burkitt Lymphoma 68Lymphoma, Mantle-Cell 67Lymphoma, B-Cell, Marginal Zone 67Hodgkin Disease 67Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 65Lymphoma, Large-Cell, Immunoblastic 65Lymphoma, Large-Cell, Anaplastic 62Lymphoma 58Immunoblastic Lymphadenopathy 56Intraocular Lymphoma 43Breast Neoplasms 41Skin Neoplasms 40Neoplasms 37Carcinoma, Renal Cell 35Waldenstrom Macroglobulinemia 33Neoplasm Metastasis 33Uveal Melanoma 29Leukemia, Myeloid, Acute 23Leukemia, Hairy Cell 23Carcinoma, Non-Small-Cell Lung 22Sarcoma 21

Interventions

veliparib 1Taxes 1Paclitaxel 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NIH × Renal Insufficiency × Dermatologic × Clear all
NCT01366144 2026-04-13

Veliparib, Paclitaxel, and Carboplatin in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery and Liver or Kidney Dysfunction

National Cancer Institute (NCI)

Phase 1 Active not recruiting
94 enrolled
BreastDermatologicGastrointestinalGenitourinaryGynecologicHead & NeckThoracic

Breast Neoplasms, Carcinoma, Transitional Cell, Esophageal Neoplasms, Head and Neck Neoplasms, Lung Neoplasms, Melanoma, Neoplasm Metastasis, Neoplasms, Unknown Primary, Ovarian Neoplasms, Testicular Neoplasms, Endometrial Neoplasms, Liver Failure, Renal Insufficiency

Data powered by HemOnc (CC BY 4.0) Colophon âš¡